Concerning that IL-22 might function like a double-edged sword during T2DM and CAD pathogenesis, the timing of IL-22–IL-22R1 application is crucial during the treatment of T2DM and CAD. The gene discussed is IL22; the disease is type 2 diabetes mellitus.